July 28, 2018
Article
An Extraordinary Healer essay honoring WYNDELON “NIKKI” SIMMONS, B.S.N., RN, OCN [UNIVERSITY OF MISSISSIPPI MEDICAL CENTER CANCER INSTITUTE, JACKSON, MISSISSIPPI]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC